有观点,有态度这是医业观察的第2505-7期文章来源:基因江湖最近,Illumina发布2025Q1季度报及电话会,公众号循因缉药、我是建设者已有详细解读。我们重点聚焦在Illumina及管理层对中国市场的判断。汇总一些信息:(1)2025Q1,Illumina总营收10.4亿美元,与去年同期(10.6亿美元)基本持平,其中大中华区营业收入0.72亿美元,同比下降6%;(但Q1大中华区占全球营收...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.